• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

以色列 2010 年肺炎支原体大环内酯类耐药性。

Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010.

机构信息

Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

出版信息

Emerg Infect Dis. 2011 Jun;17(6):1079-82. doi: 10.3201/eid/1706.101558.

DOI:10.3201/eid/1706.101558
PMID:21749775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3358208/
Abstract

Macrolide resistance in Mycoplasma pneumoniae is often found in Asia but is rare elsewhere. We report the emergence of macrolide-resistant M. pneumoniae in Israel and the in vivo evolution of such resistance during the treatment of a 6-year-old boy with pneumonia.

摘要

肺炎支原体的大环内酯类耐药性在亚洲很常见，但在其他地方很少见。我们报告了以色列出现了耐大环内酯类肺炎支原体，以及在治疗一名 6 岁男孩肺炎期间这种耐药性在体内的演变情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4b/3358208/c3f3c148fc7e/10-1558-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4b/3358208/2006e89c0c3b/10-1558-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4b/3358208/c3f3c148fc7e/10-1558-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4b/3358208/2006e89c0c3b/10-1558-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b4b/3358208/c3f3c148fc7e/10-1558-F2.jpg

相似文献

1
Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010.以色列 2010 年肺炎支原体大环内酯类耐药性。
Emerg Infect Dis. 2011 Jun;17(6):1079-82. doi: 10.3201/eid/1706.101558.
2
Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.日本 2008-2015 年耐大环内酯类肺炎支原体感染。
Emerg Infect Dis. 2017 Oct;23(10):1703-1706. doi: 10.3201/eid2310.170106.
3
Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure.与大环内酯类药物治疗失败相关的严重耐大环内酯类肺炎支原体肺炎
J Microbiol Immunol Infect. 2016 Feb;49(1):127-30. doi: 10.1016/j.jmii.2014.11.003. Epub 2014 Nov 11.
4
Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.6 岁男孩患耐大环内酯类肺炎支原体所致重症社区获得性肺炎。
Hong Kong Med J. 2011 Oct;17(5):407-9.
5
Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012.2008 年至 2012 年中国北京地区大环内酯类耐药肺炎支原体的监测。
Antimicrob Agents Chemother. 2013 Mar;57(3):1521-3. doi: 10.1128/AAC.02060-12. Epub 2012 Dec 21.
6
Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011.韩国肺炎支原体大环内酯类耐药性，2000-2011 年。
Emerg Infect Dis. 2013 Aug;19(8):1281-4. doi: 10.3201/eid1908.121455.
7
Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.社区获得性肺炎儿科患者中肺炎支原体对大环内酯类药物耐药性增加。
Antimicrob Agents Chemother. 2008 Jan;52(1):348-50. doi: 10.1128/AAC.00779-07. Epub 2007 Oct 22.
8
Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with community-acquired pneumonia: clinical impact of mutations conferring macrolide resistance.肺炎支原体 23S rRNA 基因突变频率在儿童和成人社区获得性肺炎中的差异：突变赋予大环内酯类耐药的临床影响。
Antimicrob Agents Chemother. 2012 Dec;56(12):6393-6. doi: 10.1128/AAC.01421-12. Epub 2012 Sep 24.
9
Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014.2006 年至 2014 年斯洛文尼亚中部分离的呼吸道感染患者肺炎支原体的流行率、基因分型和大环内酯类耐药性。
Euro Surveill. 2015;20(37). doi: 10.2807/1560-7917.ES.2015.20.37.30018.
10
Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.大环内酯类抗生素治疗儿童肺炎支原体肺炎中基因决定的大环内酯类耐药的临床疗效。
Respirology. 2012 Feb;17(2):354-62. doi: 10.1111/j.1440-1843.2011.02102.x.

引用本文的文献

1
A study on viruses and bacteria with particular interest on Mycoplasma pneumoniae in children with exacerbation of asthma from a tertiary care hospital in Sri Lanka.一项针对斯里兰卡一家三级护理医院中哮喘加重患儿的病毒和细菌的研究，尤其关注肺炎支原体。
Access Microbiol. 2024 Jul 30;6(7). doi: 10.1099/acmi.0.000778.v5. eCollection 2024.
2
[Macrolide-resistant Mycoplasma pneumoniae: Do we know the situation in Europe?].[耐大环内酯类肺炎支原体：我们了解欧洲的情况吗？]
Rev Esp Quimioter. 2023 Jun;36(3):259-266. doi: 10.37201/req/118.2022. Epub 2023 Mar 27.
3
Viral and Bacterial Respiratory Pathogens during the COVID-19 Pandemic in Israel.

本文引用的文献

1
Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing.焦磷酸测序法测定肺炎支原体大环内酯类药物耐药性及分子分型。
J Microbiol Methods. 2010 Sep;82(3):214-22. doi: 10.1016/j.mimet.2010.06.004. Epub 2010 Jun 11.
2
High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China.中国成人和青少年呼吸道感染肺炎支原体分离株中大环内酯类耐药率高。
Clin Infect Dis. 2010 Jul 15;51(2):189-94. doi: 10.1086/653535.
3
Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.
以色列新冠疫情期间的病毒和细菌呼吸道病原体
Microorganisms. 2023 Jan 9;11(1):166. doi: 10.3390/microorganisms11010166.
4
Point-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction.即时检测肺炎支原体的分子诊断，包括使用荧光淬灭探针聚合酶链反应检测大环内酯类药物敏感性。
PLoS One. 2021 Oct 14;16(10):e0258694. doi: 10.1371/journal.pone.0258694. eCollection 2021.
5
Update on the Epidemiology of Macrolide-Resistant in Europe: A Systematic Review.欧洲大环内酯类耐药流行病学最新情况：一项系统评价
Infect Dis Rep. 2021 Sep 2;13(3):811-820. doi: 10.3390/idr13030073.
6
infections, 11 countries in Europe and Israel, 2011 to 2016.2011 年至 2016 年期间，欧洲 11 个国家和以色列的感染情况。
Euro Surveill. 2020 Jan;25(2). doi: 10.2807/1560-7917.ES.2020.25.2.1900112.
7
Allele-specific real-time PCR testing for minor macrolide-resistant Mycoplasma Pneumoniae.针对小剂量大环内酯类耐药肺炎支原体的等位基因特异性实时 PCR 检测。
BMC Infect Dis. 2019 Jul 12;19(1):616. doi: 10.1186/s12879-019-4228-4.
8
Rapid Detection of the Macrolide Sensitivity of Pneumonia-Causing Mycoplasma pneumoniae Using Quenching Probe Polymerase Chain Reaction (GENECUBE).采用淬灭探针聚合酶链反应（GENECUBE）快速检测肺炎支原体引起肺炎的大环内酯类药物敏感性
Mol Diagn Ther. 2018 Dec;22(6):737-747. doi: 10.1007/s40291-018-0360-x.
9
Multilocus Sequence Typing of Mycoplasma pneumoniae, Japan, 2002-2016.2002-2016 年日本肺炎支原体多位点序列分型。
Emerg Infect Dis. 2018 Oct;24(10):1895-1901. doi: 10.3201/eid2410.171194.
10
A study of community-acquired in Yantai, China.中国烟台一项关于社区获得性（疾病）的研究。 （原句表述不完整，推测补充完整后大致是这样的意思，因为“A study of community-acquired...”后面缺少具体所研究的关于社区获得性的内容，比如疾病等）
Colomb Med (Cali). 2018 Jun 30;49(2):160-163. doi: 10.25100/cm.v49i2.3813.
大环内酯类耐药肺炎支原体：分离株的特征和社区获得性肺炎的临床方面。
J Infect Chemother. 2010 Apr;16(2):78-86. doi: 10.1007/s10156-009-0021-4. Epub 2010 Jan 22.
4
Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany.德国大环内酯类耐药肺炎支原体株的发生情况。
Clin Microbiol Infect. 2010 Jun;16(6):613-6. doi: 10.1111/j.1469-0691.2009.02968.x. Epub 2009 Sep 17.
5
Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae.由大环内酯类耐药肺炎支原体引起的成人社区获得性肺炎。
Respirology. 2009 Nov;14(8):1206-8. doi: 10.1111/j.1440-1843.2009.01619.x. Epub 2009 Sep 1.
6
Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.儿童肺炎支原体新出现的大环内酯类耐药性：耐药菌株的检测与特征分析
Pediatr Infect Dis J. 2009 Aug;28(8):693-6. doi: 10.1097/INF.0b013e31819e3f7a.
7
Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.通过实时聚合酶链反应和熔解曲线分析直接在临床标本中检测到法国肺炎支原体对大环内酯类药物的耐药性增加。
J Antimicrob Chemother. 2009 Jul;64(1):52-8. doi: 10.1093/jac/dkp160. Epub 2009 May 9.
8
Genotyping of Mycoplasma pneumoniae isolates using real-time PCR and high-resolution melt analysis.使用实时荧光定量聚合酶链反应和高分辨率熔解曲线分析对肺炎支原体分离株进行基因分型。
Clin Microbiol Infect. 2009 Aug;15(8):756-62. doi: 10.1111/j.1469-0691.2009.02814.x. Epub 2009 Apr 23.
9
Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China.中国肺炎支原体临床分离株大环内酯类耐药的分子机制
Antimicrob Agents Chemother. 2009 May;53(5):2158-9. doi: 10.1128/AAC.01563-08. Epub 2009 Mar 9.
10
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.中国上海肺炎支原体分离株的抗菌药敏性及大环内酯类耐药菌株的分子分析
Antimicrob Agents Chemother. 2009 May;53(5):2160-2. doi: 10.1128/AAC.01684-08. Epub 2009 Mar 9.